NEW ULM, Minn. » Authorities nationwide were on the lookout Wednesday for a mother and her 13-year-old cancer-stricken son who fled after refusing the chemotherapy that doctors say could save the boy’s life.
Colleen Hauser and her son, Daniel, who has Hodgkin’s lymphoma, apparently left their southern Minnesota home sometime after a doctor’s appointment and court-ordered X-ray on Monday showed his tumor had grown.
Brown County District Judge John Rodenberg, who had ruled last week that Daniel’s parents were medically neglecting him, issued an arrest warrant Tuesday for Colleen Hauser and ruled her in contempt of court. Rodenberg also ordered that Daniel be placed in foster care and immediately evaluated by a cancer specialist for treatment.
The family belongs to a religious group that believes in “natural” healing methods. Daniel has testified he believed chemotherapy would kill him and told the judge that if anyone tried to force him to take it, “I’d fight it. I’d punch them and I’d kick them.”
The boy’s father, Anthony Hauser, testified he didn’t know where his wife and son were but had made no attempt to find them. He testified he last saw his son Monday morning, and he saw his wife only briefly that evening when she said she was leaving “for a time.”
As of Wednesday morning, the mother and son still had not been found, said Carl Rolloff, a sheriff’s dispatcher.
the arrest warrant nationwide. Brown County Sheriff Rich Hoffman said Tuesday that investigators were following some leads locally, but declined to elaborate. A crime alert said the Hausers might be with Susan Daya, also known as Susan Hamwi, a California attorney who accompanied them to a medical appointment Monday, or with a man named Billy Joe Best.It wasn’t immediately clear who Best was. A Brown County deputy said he was unsure of his connection to the case.
“It’s absolutely crazy. It’s very disappointing,” James Olson, the attorney representing Brown County Family Services. “We’re trying to do what’s right for this young man.”
In an interview Wednesday at his family farm in Sleepy Eye, Anthony Hauser said he hadn’t heard from his wife or Daniel since they left. He said he has some ideas where they might have gone, and he’s shared them with authorities.
He said he doesn’t think his wife wants to harm Daniel. He thinks she just got scared when they got the results of the X-ray on Monday, and thought Brown County authorities would use it to try to get custody of Daniel.
“It’s just my opinion, but I think she figured that because of that X-ray she feared they were going to take him,” he said.
He said he doesn’t oppose chemotherapy “if it’s a necessary thing,” but thinks doctors use it too much.
He said he was trying to stay busy so he doesn’t think about his missing wife and sick son, and wonders why Brown County authorities got involved.
“I don’t know why they started this situation in the first place,” he said. “Why does someone believe they have the right over your child?”
Olson, the family services lawyer, had considered asking the judge to hold Anthony Hauser in contempt as well, but he said Wednesday he decided against that.
“I’m thinking that he probably doesn’t know where his wife and child are,” Olson said.
Daniel’s Hodgkin’s lymphoma, diagnosed in January, is considered highly curable with chemotherapy and radiation, but the boy quit chemo after a single treatment.
The judge has said Daniel, who has a learning disability and cannot read, did not understand the risks and benefits of chemotherapy and didn’t believe he was ill.
The Hausers are Roman Catholic and also believe in the “do no harm” philosophy of the Nemenhah Band, a Missouri-based religious group that believes in natural healing methods advocated by some American Indians. Colleen Hauser testified earlier that she had been treating his cancer with herbal supplements, vitamins, ionized water and other natural alternatives.
The founder of Nemenhah, Philip Cloudpiler Landis, said it was a bad idea for Colleen Hauser to flee with her son. “You don’t solve anything by disregarding the order of the judge,” Landis said.
The family’s doctor, James Joyce, testified by telephone that he examined Daniel on Monday, and that an X-ray showed his tumor had grown to the size it was when he was first diagnosed.
“He had basically gotten back all the trouble he had in January,” the doctor said.
Joyce testified that he offered to make appointments for Daniel with oncologists, but the Hausers declined, then left in a rush with lawyer Susan Daya.
“Under Susan Daya’s urging, they indicated they had other places to go,” Joyce said.
Daya did not immediately respond to a call Tuesday from The Associated Press. The court also tried to reach her during the hearing, but got no answer.
Minnesota statutes require parents to provide necessary medical care for a child, Rodenberg wrote. The statutes say alternative and complementary health care methods aren’t enough
Darrel,i just learned last week i have a lifetime friend that
definitely has breast cancer in Oklahoma..
she is preparing to go with radiation or chemo..
what is the cure you were talking about,i’d like
to talk her out of what she’s doing.
she’s had lympenode cancer yrs ago and went
the radiation route with it..bet it brought this
Sorry to hear of the beginning of your friends ordeal with the American Cancer Industry.
One question only.
How much of NOW are you willing to sacrifice for how many promised tomorrows?
If the NOW investment is small and the promised tomorrows are many, go for it!
If the NOW investment of time, energy, family, money, and joy filled moments IS GREAT and the promised number of tomorrows is not stated or small, then investigate other options. While remembering to enjoy NOW which ever way you choose.
Simple as that. Which ever way she decides, support her to the end. I am sure you already understand, the last thing someone needs when confronting their mortality is judgment.
Floride is promoted as being important for your teeth. All the science and clinical evidence shows not only is Floride NOT good for you, but it is VERY poisonous. Please watch this.
Acupuncture works, but it appears to work equally well with or without needle penetration. This conclusion was drawn from a treatment study involving cancer patients suffering from nausea during radiotherapy.
In a series of acupuncture studies that involved more than 200 patients who were undergoing radiation treatment, roughly half received traditional acupuncture with needles penetrating the skin in particular points, while the others received simulated acupuncture instead, with a telescopic, blunt placebo needle that merely touched their skin.
Afterwards, 95 percent of the patients in both groups felt that the treatment had helped relieve nausea, and 67 percent had experienced other positive effects such as improved sleep, brighter mood, and less pain. Both groups felt considerably better than a separate control group that received no acupuncture of any kind.
The acupuncture was performed by physiotherapists two or three times a week during the five week long period of their radiation treatment.
The fact is clear that in primitive societies, people don’t die of cancer. This is supposed to be because they are healthier and eat properly. But who dares think the unthinkable: that the cause of the problem is doctors and when you don’t have them, cancer is insignificant?
It’s only when doctors using Western methods get involved that cancer actually becomes a problem at all. Then it’s suddenly a serious and probably fatal condition.
But it may be time for a re-think. Yesterday a major study was published which could change EVERYTHING doctors know and think about cancer. (continue reading here)
Macrophage Activation May Suppress Breast Cancer Metastasis
By David Douglas
NEW YORK FEB 20, 2008 (Reuters Health) – Vitamin D-binding protein-derived macrophage activating factor (Gc-MAF) appears to be an effective immunotherapeutic agent in patients with metastatic breast cancer, according to US and Japanese researchers.
“Serum vitamin D-binding protein – known as Gc protein – is the precursor of the principal macrophage activating factor,” lead investigator Dr. Nobuto Yamamoto told Reuters Health.
“Treatment of purified Gc protein with beta-galactosidase and sialidase generates Gc-MAF,” he added, “the most potent macrophage activating factor ever discovered, which produces no side effect in humans.”
Dr. Yamamoto of the Socrates Institute for Therapeutic Immunology, Philadelphia and colleagues note that in vitro studies show that macrophages treated with Gc-MAF have a highly tumoricidal effect in mammary adenocarcinomas.
To investigate whether the approach can be effective in humans, the researchers studied 16 non-anemic breast cancer patients who were given “a minute amount – 100 nanograms per week – of Gc-MAF,” Dr. Yamamoto said.
The researchers found that after 16 to 22 Gc-MAF doses, initially elevated nagalase levels, which reflect the tumor burden, fell to those found in healthy controls. Follow-up over 4 years showed that the level remained low and that there was no tumor recurrence, they report in the January 15th issue of The International Journal of Cancer.
The findings, the team concludes, clearly demonstrate “the importance of focusing cancer immunotherapy on macrophage activation.”
International Journal Cancer. 2008 Jan 15; 122(2):461-7.
Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (Gc-MAF).
Division of Cancer Immunology and Molecular Biology, Socrates Institute for Therapeutic Immunology, Philadelphia, PA 19126-3305, USA. email@example.com
Serum vitamin D3-binding protein (Gc protein) is the precursor for the principal macrophage activating factor (MAF). The MAF precursor activity of serum Gc protein of breast cancer patients was lost or reduced because Gc protein was deglycosylated by serum alpha-N-acetylgalactosaminidase (Nagalase) secreted from cancerous cells. Patient serum Nagalase activity is proportional to tumor burden. The deglycosylated Gc protein cannot be converted to MAF, resulting in no macrophage activation and immunosuppression. Stepwise incubation of purified Gc protein with immobilized beta-galactosidase and sialidase generated probably the most potent macrophage activating factor (termed Gc-MAF) ever discovered, which produces no adverse effect in humans. Macrophages treated in vitro with Gc-MAF (100 pg/ml) are highly tumoricidal to mammary adenocarcinomas. Efficacy of Gc-MAF for treatment of metastatic breast cancer was investigated with 16 nonanemic patients who received weekly administration of Gc-MAF (100 ng). As Gc-MAF therapy progresses, the MAF precursor activity of patient Gc protein increased with a concomitant decrease in serum Nagalase. Because of proportionality of serum Nagalase activity to tumor burden, the time course progress of Gc-MAF therapy was assessed by serum Nagalase activity as a prognostic index. These patients had the initial Nagalase activities ranging from 2.32 to 6.28 nmole/min/mg protein. After about 16-22 administrations (approximately 3.5-5 months) of Gc-MAF, these patients had insignificantly low serum enzyme levels equivalent to healthy control enzyme levels, ranging from 0.38 to 0.63 nmole/min/mg protein, indicating eradication of the tumors. This therapeutic procedure resulted in no recurrence for more than 4 years. Copyright 2007 Wiley-Liss, Inc.
Cancer Immunology, Immunotherapy 2008 July 57 (7): online
Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, Gc-MAF
Nobuto Yamamoto, Hirofumi Suyama, Hiroaki Nakazato, Nobuyuki Yamamoto and Yoshihiko Koga
Abstract: Serum vitamin D binding protein (Gc protein) is the precursor for the principal macrophage-activating factor (MAF). The MAF precursor activity of serum Gc protein of colorectal cancer patients was lost or reduced because Gc protein is deglycosylated by serum α-N-acetylgalactosaminidase (Nagalase) secreted from cancerous cells. Deglycosylated Gc protein cannot be converted to MAF, leading to immunosuppression. Stepwise treatment of purified Gc protein with immobilized β-galactosidase and sialidase generated the most potent macrophage-activating factor (Gc-MAF) ever discovered, but it produces no side effect in humans. Macrophages treated with Gc-MAF (100 pg/ml) develop an enormous variation of receptors and are highly tumoricidal to a variety of cancers indiscriminately. Administration of 100 nanogram (ng)/human maximally activates systemic macrophages that can kill cancerous cells. Since the half-life of the activated macrophages is approximately 6 days, 100 ng Gc-MAF was administered weekly to eight nonanemic colorectal cancer patients who had previously received tumor-resection but still carried significant amounts of metastatic tumor cells. As Gc-MAF therapy progressed, the MAF precursor activities of all patients increased and conversely their serum Nagalase activities decreased. Since serum Nagalase is proportional to tumor burden, serum Nagalase activity was used as a prognostic index for time course analysis of Gc-MAF therapy. After 32–50 weekly administrations of 100 ng Gc-MAF, all colorectal cancer patients exhibited healthy control levels of the serum Nagalase activity, indicating eradication of metastatic tumor cells. During 7 years after the completion of Gc-MAF therapy, their serum Nagalase activity did not increase, indicating no recurrence of cancer, which was also supported by the annual CT scans of these patients.
May 22, 2008